Literature DB >> 9427179

Orbital aspergillosis. A fatal masquerader.

C M Hutnik1, D A Nicolle, D G Munoz.   

Abstract

Ocular manifestations of aspergillosis are emerging as increasingly more atypical, with a wide spectrum of presentations. The classic teaching is that this fungus presents as an endogenous endophthalmitis in immunocompromised hosts. In most other ocular conditions, the index of suspicion for this infection has typically been low, especially in apparently immunocompetent individuals. However, reports continue to appear that confirm involvement of Aspergillus species in a wide variety of primary ocular and orbital conditions characterized by rapid, uncontrollable progression and, not uncommonly, death. This report highlights a case of autopsy-proven orbital aspergillosis that masqueraded as temporal arteritis in terms of initial clinical presentation and response to standard therapy. Any ocular condition that manifests even subtle atypical features, including temporal arteritis, should be regarded as suspect, and an aggressive approach to secure a biopsy of any involved sites should follow.

Entities:  

Mesh:

Year:  1997        PMID: 9427179

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  3 in total

Review 1.  Localised invasive sino-orbital aspergillosis: characteristic features.

Authors:  J A Sivak-Callcott; N Livesley; R A Nugent; S L Rasmussen; P Saeed; J Rootman
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

2.  Fungal Orbital Cellulitis: Presenting Features, Management and Outcomes at a Referral Center.

Authors:  Asim V Farooq; Rakesh M Patel; Amy Y Lin; Pete Setabutr; Juliana Sartori; Vinay K Aakalu
Journal:  Orbit       Date:  2015-04-23

3.  Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient.

Authors:  Ilya Leyngold; Alessandro Olivi; Masaru Ishii; Ari Blitz; Peter Burger; Prem S Subramanian; Gary Gallia
Journal:  World Neurosurg       Date:  2013-08-20       Impact factor: 2.104

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.